Do you use delayed-release budesonide over prednisone or methylprednisolone for the treatment of IgA nephropathy, considering the available safety and efficacy data?
Community PollStarted
Do you prefer to use delayed-release budesonide over prednisone or methylprednisolone for the treatment of IgA nephropathy, considering the available safety and efficacy data?
88 physicians have voted
Join Mednetto vote and see how they answered.
2 Answers
Mednet MemberInvited Expert
Nephrology · NewYork-Presbyterian / Columbia University Irving Medical Center
Answered on
The two agents (TRF-budesonide and systemic glucocorticoids, the latter of which include prednisone and methylprednisolone) have never been compared head-to-head, and so direct comparisons are unavailable. I try to present both options to patients, and in particular, I will focus on the side effect ...
Join for free or sign in to see the full answer
Mednet Member
Nephrology · University of Chicago Medicine
Answered on · Updated on
The side effects of chronic prednisone at a high or even medium dose can be really harmful, so you can't keep patients on prednisone on a long-term basis. Budesonide is an attractive option for these patients because it's better tolerated. Although I will point out that despite its first-pass metabo...
Join for free or sign in to see the full answer